a16zTaking Bold Bets: NIH and the Future of Biomedical Science
CHAPTERS
Why public trust depends on evidence, transparency, and productive failure
Bhattacharya opens with a thesis about rebuilding trust: treat the public as intelligent partners, show the data, and allow disagreement. He argues science should adopt a “Silicon Valley spirit” that rewards learning—including learning from failure—rather than punishing it.
Autism Data Science Initiative: $50M, 13 teams, and a push for causes & prevention
He announces a new NIH autism effort prompted by rising prevalence and lack of clear answers for families. The initiative funds large, data-science-oriented projects intended to accelerate understanding of causes and potential prevention strategies.
Clinical signals in focus: leucovorin for subsets of autism and caution on Tylenol in pregnancy
Two additional announcements highlight translation to care: expanding access to leucovorin (folinic acid) for specific folate-processing issues, and updated caution/guidance around acetaminophen use during pregnancy. He emphasizes nuance—potential benefits for some, uncertainty for others—and avoiding panic while acting prudently.
Preterm birth as a national outcomes gap and a family-centered research mandate
The conversation expands to preterm birth, noting the U.S. has worse outcomes than parts of Europe and lacks sufficient explanations. Bhattacharya frames NIH’s role as delivering rigorous science that responds to real family concerns, while acknowledging complexity and multiple contributing factors.
The replication crisis: why “published” doesn’t mean “true”
Bhattacharya diagnoses replication as the core standard for scientific truth and argues current incentives undervalue verification. He attributes the crisis to the difficulty and scale of modern science, specialization, and weak incentives to check others’ work or publish negative/failed replications.
NIH reform agenda: auditability, centralized review, and modernizing collaboration oversight
Reflecting on his first months, he highlights operational reforms: strengthening accountability for foreign collaborations and centralizing grant review processes. He argues these changes preserve global collaboration while ensuring the U.S. can track funds and verify compliance.
Bringing venture-style portfolio thinking to NIH: bold bets, tolerance for failure, and newer ideas
He draws a direct analogy to venture capital portfolios: many failures can be acceptable if the portfolio produces transformative wins. He argues NIH became more conservative over time—funding older, safer ideas—and needs to renew incentives for experimentation and learning.
Allocation vs execution: who decides priorities, and why politics can’t be removed
Agarwala frames NIH’s challenge as both allocating dollars across areas and executing well within each area; Bhattacharya agrees and explains why public (political) input is appropriate for macro allocation. He argues scientists are essential within-area decision makers, but not legitimate “philosopher kings” for societal tradeoffs.
Early-career investigator bottleneck: aging of first grants, postdoc inflation, and new incentives
Bhattacharya describes how the system increasingly delays independence for young scientists, shifting first major grants from mid-30s to mid-40s and encouraging multiple postdocs. He proposes changes that judge institutes on portfolio outcomes, strengthen alignment to strategic plans, and reward mentorship and early-career support.
Training and the “missing link”: bridging from training grants to faculty independence
The discussion turns to NIH training mechanisms (pre-doc, postdoc, MSTP) and where attrition occurs. Bhattacharya argues the biggest failure point is the transition from training to independent positions and that NIH should reward institutions and structures that make that leap feasible.
Rebuilding public health trust after the pandemic: gold-standard science and humility
Bhattacharya links today’s trust deficit directly to pandemic-era policies he views as weakly evidenced and harmful. He proposes two pillars for repair: enforce “gold-standard science” norms (replication, unbiased review, humility) and reframe public health as servant-partner to the public rather than a commanding authority.
Communicating uncertainty: say ‘I don’t know,’ avoid false certainty, and invite open debate
He argues that in uncertain situations, honesty about unknowns is essential and that overconfident guidance erodes credibility. At the same time, he distinguishes between areas of genuine uncertainty and areas with strong evidence (e.g., MMR), advocating open scientific discourse rather than censorship or “canceling.”
NIH priorities: chronic disease, nutrition, and AI—plus practical examples like Alzheimer’s prevention signals
Bhattacharya outlines priorities including chronic disease burden and integrating AI, emphasizing translational opportunities. He highlights observational findings suggesting an old shingles vaccine (Zostavax) may reduce Alzheimer’s cognitive decline risk, illustrating the kind of pragmatic, high-upside hypothesis he wants to pursue.
The role and limits of AI: augmentation over substitution, plus guarding against system noise
AI’s promise includes protein-structure tools (e.g., AlphaFold), radiology assistance, and reducing clinician documentation burden. But Bhattacharya warns of hallucinations, low-quality AI-generated grant spam, and the need for policies that keep AI from overwhelming review systems while enabling secure internal use.
Advice to scientists: persist like Max Perutz—and why portfolios must allow long, uncertain bets
Closing advice centers on resilience and conviction: transformative discoveries often require years of persistence despite skepticism. He uses Max Perutz’s decade-long pursuit of protein structure to argue NIH must create conditions where such long-horizon, high-risk work can survive and succeed.
Get more out of YouTube videos.
High quality summaries for YouTube videos. Accurate transcripts to search & find moments. Powered by ChatGPT & Claude AI.
Add to Chrome